Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.

Members of the IL-6 family of cytokines, which includes leukemia inhibitory factor (LIF) and IL-11, play important roles in implantation. The activity of these cytokines is modified by soluble receptors such as the IL-6 receptor (sIL-6R). gp130 is a signal transduction molecule common to the receptor complexes of this family, and its soluble form (sgp130) antagonizes their actions. The purpose of this study was to determine whether secretion of IL-6, LIF, sIL-6R, and sgp130 was different in the endometrium of women with primary unexplained infertility compared with normal fertile women. Endometrial biopsies were taken between d LH+6 and +13 and cultured in serum-free medium for 4 h. Secretion of IL-6, LIF, sIL-6R, and sgp130 was measured in the supernatant by ELISA. We also measured the secretion of IL-6, sIL-6R, and sgp130 by endometrial biopsies taken throughout the menstrual cycle in normal fertile women. Secretion of sgp130 increased 20-fold between d 20 and 26 of the cycle, coinciding with the implantation window (proliferative phase, median, 27.0 pg/ml.mg; range, 23-36; d 20-26, median, 501.5 pg/ml x mg; range, 26.1-1344; P = 0.03). RT-PCR showed that none of the known splice variants of gp130 were present in endometrium, indicating that sgp130 is produced by proteolytic cleavage of the membrane-bound form. IL-6 secretion varied considerably between patients and was greatest during the secretory phase and at menstruation. No significant change was seen in sIL-6R during the cycle. Between LH+6 and +13, secretion of sgp130 was significantly reduced in the infertile group (median, 93.1 pg/ml.mg; range, 28.5-256; compared with the fertile group, median, 223 pg/ml x mg; range, 63-534; U-statistic = 37; P = 0.017). Secretion of IL-6, LIF, and sIL-6R did not differ between the two groups. Immunolocalization of gp130, IL-6R, and the LIF receptor showed that the glandular epithelium and also endothelial cells are targets for IL-6 and LIF. These findings show that during a normal menstrual cycle, sgp130 secretion is greatly increased between d LH+6 and +13, due to proteolytic cleavage of membrane-bound gp130. Infertile patients show reduced secretion of sgp130 compared with fertile controls during this period, which coincides with the implantation window.

[1]  C. Stewart,et al.  Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. , 2000, Endocrinology.

[2]  H. M. Beier,et al.  The endometrium as a novel target for leptin: differences in fertility and subfertility. , 2000, Molecular human reproduction.

[3]  Yiqiang Cai,et al.  Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  K. Nakao,et al.  Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. , 2000, The Journal of clinical investigation.

[5]  C. Weinberg,et al.  Time of implantation of the conceptus and loss of pregnancy. , 1999, The New England journal of medicine.

[6]  A. Pellicer,et al.  Cytokine pleiotropy and redundancy--gp130 cytokines in human implantation. , 1999, Immunology today.

[7]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[8]  C. Simón,et al.  Molecular interactions between embryo and uterus in the adhesion phase of human implantation. , 1998, Human reproduction.

[9]  L. D. Ward,et al.  Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor α-Chain in Normal Human Urine and Plasma* , 1998, The Journal of Biological Chemistry.

[10]  C. Begley,et al.  Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation , 1998, Nature Medicine.

[11]  E. Hambartsoumian.  Endometrial Leukemia Inhibitory Factor (LIF) as a Possible Cause of Unexplained Infertility and Multiple Failures of Implantation , 1998, American journal of reproductive immunology.

[12]  E. Tartour,et al.  Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  N. Chegini,et al.  Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily association of gene expression with endometrial bleeding. , 1997, The Journal of clinical investigation.

[14]  X. Zhang,et al.  The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. , 1997, Human reproduction.

[15]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[16]  D. Vandermolen,et al.  Human endometrial interleukin-6 (IL-6): in vivo messenger ribonucleic acid expression, in vitro protein production, and stimulation thereof by IL-1 beta. , 1996, Fertility and sterility.

[17]  R. Naz,et al.  Interleukins‐6 and −8 Levels in Sera and Cervical Mucus of Fertile, Idiopathic Infertile, and Immunoinfertile Women: Implication in Infertility , 1996, American journal of reproductive immunology.

[18]  J. Pollard,et al.  Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Salamonsen,et al.  Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle. , 1996, The Journal of endocrinology.

[20]  Stephen K. Smith,et al.  Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. , 1995, Biology of reproduction.

[21]  S. Tabibzadeh,et al.  Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. , 1995, Human reproduction.

[22]  R. Fanchin,et al.  Molecular aspects of implantation: In-vitro endometrial secretion of human interleukin for DA cells/ leukaemia inhibitory factor by explant cultures from fertile and infertile women , 1995 .

[23]  R. Fanchin,et al.  In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. , 1995, Human reproduction.

[24]  D. Hilton,et al.  Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays. , 1995, Leukemia.

[25]  A. Arıcı,et al.  Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. , 1995, The Journal of clinical endocrinology and metabolism.

[26]  S. Tabibzadeh,et al.  The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. , 1995, Human reproduction.

[27]  Jinghai Sun,et al.  Integrins as markers of uterine receptivity in women with primary unexplained infertility. , 1995, Fertility and sterility.

[28]  L. Orci,et al.  Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. , 1995, Journal of cell science.

[29]  D. Charnock-Jones,et al.  Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. , 1994, Journal of reproduction and fertility.

[30]  B. Modrell,et al.  LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. , 1994, Growth factors.

[31]  D. Charnock-Jones,et al.  Expression of mRNA for vascular endothelial growth factor in human placenta. , 1993, Journal of reproduction and fertility.

[32]  P. Heinrich,et al.  Differential shedding of the two subunits of the interleukin‐6 receptor , 1993, FEBS letters.

[33]  G. Yancopoulos,et al.  Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. , 1993, Blood.

[34]  P. Heinrich,et al.  The soluble interleukin‐6 receptor is generated by shedding , 1993, European journal of immunology.

[35]  T. Saito,et al.  Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Stewart,et al.  Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.

[37]  C. Stewart,et al.  Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[39]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Sachs,et al.  Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.

[42]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.